Early diagnosis of colorectal cancer (CRC) is clinically critical but technically challenging,
especially in a minimal-invasive way. Emerging evidence suggests that exosome …

Background: Circulating exosomal miRNAs are potential non-invasive biomarkers for
colorectal cancer. The present study aimed to validate the novel sensitive and specific …

Aim: This study aimed to identify specific and sensitive exosomal miRNAs in diagnosing
patients with colorectal cancer (CRC). Methods: Serum exosomes were isolated from 175 …

Circulating exosome holds great potentials as biomarker for diagnosis and prognosis of
human cancers. Previously, we have applied small RNA sequencing to identify aberrantly …

OBJECTIVE: Emerging evidence has indicated that serum exosomal microRNAs (miRNAs)
have promising diagnostic and prognostic value for colorectal cancer (CRC). This study …

Background: Liver is the most common site for metastatic spread of CRC at the time of
diagnosis which leads to high mortality. This study aimed to identify novel circulating …

Exosome-encapsulated microRNAs have been recognized as novel and stable biomarkers
for cancer. However, little is known about the role of exosomal microRNAs in colon cancer …

Growing evidence have revealed the serum exosomal miRNAs emerged as biomarkers for
various cancer types, including colorectal cancer (CRC). Here, we sought to explore the …

Background To identify specific exosomal microRNAs (miRNAs) as serum biomarkers for
prediction of metastasis in patients with colorectal cancer (CRC). Materials and Methods …

BACKGROUND Early detection, early diagnosis, and early treatment are currently accepted
methods that can effectively improve the efficacy of colorectal cancer (CRC) treatment …